Instructions For Authors - A Step-by-Step Guide For Submitting A Scientific Paper
Instructions for authors are a unique set of criteria for each journal.
This assists prospective authors incorrectlyPapers constructing their manuscript and preparing it for submission.
OAPL encourages paper submissions that fulfill the broad importance and scholarly quality requirements.
COPYRIGHT_OAPL: Published on https://www.oapublishinglondon.com/hl/instructions-for-authors/ by Suleman Shah on 2022-05-19T04:14:37.922Z
- A competing interest exists when the information presented is influenced by a professional or personal relationship with a person or organization.
- The authors must declare any potential conflicts of interest, both financial and non-financial (research work).
- If an editor or peer reviewer has a competing interest, they are barred from handling the manuscript to maintain transparency throughout the editorial and peer-review process.
- This policy was implemented to publish responsible research findings and ensure that all necessary approvals and consents were obtained before the publication of the results.
- Authors must attest that their research was conducted by the procedures approved by their organizations' ethical committees. The Editor of the journal makes the final decision on the acceptance or rejection of manuscripts that have been subjected to human and animal ethics scrutiny.
- Clinical research/trials involving human data, human specimens, and human subjects must have been carried out by the 1975 Helsinki Declaration of the World Medical Association, as revised in 2008, concerning Human and Animal Rights, with the approval of an ethics committee.
- If the editor or peer reviewer requests it, justification for the clinical procedure must be provided.
- The authors are expected to obtain informed consent from human subjects for participation in the study.
- The experimental procedure and outcomes involving animal models must adhere to National or International standards. The details (guidelines/permissions/licenses) of such compliance must be included in the manuscript and appropriate references and specifications.
- Clinical data, quantitative survey observations, statistical algorithms, transcripts, experimental data, images, videos, audios, and so on are examples of scholarly data. Data can be in either raw or processed form.
- The journal encourages sharing data associated with research publications to improve the chances of accurate reproducibility, better peer-review, increased funding opportunities, and citations.
- The authors are encouraged to share their research data in open data repositories by the open access policy and license terms. Access to shared data may be indicated in publications through a URL.
- The data linked to the journal's DOI allows for precise identification and retrieval.
- For corrections, retractions, withdrawals, and concerns, the publisher follows COPE guidelines.
- Errors in publications may necessitate corrections, provided as a corrigendum or erratum with the original article citation.
- Concerns about the author's conduct, the integrity of the work, or fraudulent presentation are generally addressed with the author's sponsoring organization. The response is conveyed to the Editor-in-Chief for adequate resolution.
- This policy is in place to ensure the transparency and integrity of research communications.
- Under the following conditions, an article may be retracted: significant technical/scientific/experimental error, unrealistic presentations, data fabrication, redundant publication, plagiarism, inappropriate authorship, or unethical research.
- The authors should check plagiarism in their articles before submission to save themselves from retraction. The instances of plagiarism should be detected and removed as the Editor-in-Chief will retract articles containing plagiarized information.
- The Editor-in-Chief is the final authority on article retraction. Before retraction, the Editor evaluates the author's response and follows COPE guidelines.
- The retraction notice will be published online in the journal's next issue.
- The corresponding author may withdraw the article before publication acceptance but not after publication acceptance or peer review. Withdrawal is allowed if conclusive evidence of an ethical code violation, multiple submissions resulting in the redundant publication of the previous magazine elsewhere, or authorship claim issues.
- The publisher offers marketing solutions to commercial ventures to raise awareness among a specific target audience.
- Commercially sponsored advertisements are entirely unrelated to editorial policy or decisions.
- The publisher does not endorse any advertised products.
- The publisher ensures that commercial interests do not influence the publications.
- The Publisher retains control over the selection of advertising content.
- The Editor or Publisher retains the right to retain or withdraw online advertisements.
- Advertisements must adhere to the guidelines established by national and international advertising regulations.
Manuscripts may be submitted in a general single-spaced Word document. Figures/tables/schemas, etc., should be placed in the text where they should be based on text references, not after the Word document.
- The Title Page. Title: To give the most information in a computerized title search, the paper's title should be created with care for readability and represent the study's aims and results. Nonfunctional terms should be used as little as possible. Only frequently used acronyms (e.g., DNA, RNA, ATP) are permitted. Compound code numbers may be used in the title of a document. Avoid using complicated compound names in the title as much as possible by using generic names or code numbers, and spell out items rather than using symbols unless they are part of a compound name. The title and any accompanying material should not imply that the article is part of a numbered series in a broader research subject or a numbered contribution from a specific university or research group. Compound code numbers may be used in a manuscript title if put in parenthesis AFTER the chemical or descriptive name.
- Authors' Complete First and Last Names, Affiliations, and Addresses (Including Postal Codes): The authors' full first and last names, affiliations, and addresses (including postal codes) at the time of work completion should be provided below the title. An asterisk (*) should be placed next to the name of the relevant author.
- Abstract: Following the title page, all articles, drug annotations, perspectives, and viewpoints must have an abstract. Articles, Drug Annotations, and Perspectives typically need 150 words; Viewpoints require 50 words. Abstracts should be given in a findings-oriented fashion, summarizing the most significant results and conclusions. In the abstract, descriptive or code names may be employed.
- Introduction: This part should go through the research's rationale and aims. Background information should be concise and relevant to the study discussed.
- Results: This part might contain synthetic schemes and biological data tables. The chemical and biology discussions should be detailed. It should be noted that the findings and discussion sections might be coupled with a separate conclusions part.
- Conclusions and Discussion: If a different conclusions section is not used, the authors should describe the data analysis and the importance of the findings and conclusions.
- Experiment Section: In experimental descriptions, authors should be as brief as feasible. Only one set of general response conditions should be supplied. An experiment's title should be followed by a parenthesized code number or a firm Arabic identity number.
The purity statement "All substances are >95 percent pure by HPLC" must be included in the Experimental section. HPLC traces for representative compounds with in vitro data and all combinations with in vivo data stated in the text should be provided. Any exceptions or exclusions should be justified.
The experimental protocols for all phases in the synthesis of target compounds must be provided in the manuscript's experimental section, not in the SI.
All reactant molar equivalents and product percentage yields should be provided.
An essential introduction should cover general processes, standard techniques, and instruments used to synthesize and characterize compounds detailed later in this section (e.g., purity determination, chromatography, NMR spectra, mass spectra, and equipment names). Analyze recognized kinds of assay interference chemicals.
Authors must highlight any unexpected, novel, or severe hazards or risks connected with the presented work. This information should be included in the manuscript's experimental details section.
- Abbreviations: Throughout the experimental portion, standard abbreviations should be utilized. More popular abbreviations include mp, bp, C, K, min, h, mL, L, g, mg, g, cm, mm, nm, mol, mmol, mol, ppm, TLC, GC, NMR, UV, and IR. Units are shortened only in table column headers and when used with numbers.
- Additional Information: Include relevant material before the references in the order indicated.
- Supporting Information: Provide short summaries of the files provided as Supporting Information in non-sentence format.
- Include the PDB ID numbers with the allocated compound Arabic number. Include the sentence "Authors will disclose atomic coordinates and experimental data following the study's publication."
- Homology Models: Coordinates of homology models in PDB format should be included as Publication Supporting Information.
- Corresponding Author Information: Include email addresses for all corresponding authors.
- Author Locations: Provide information for writers whose affiliations or addresses have changed.
- Contributions by Writers: Include a sentence like "These authors contributed equally."
- Authors may honor individuals, organizations, and financial benefactors in this section.
- Abbreviations: Provide a list of nonstandard abbreviations and acronyms used in work, for example, "YFP, yellow fluorescent protein." Separate them using semicolons.
- References: The National Information Standards Organization NISO Z39.29-2005 (R2010) Bibliographic References, developed by the National Library of Medicine for its databases, is the approved reference style.
The instructions for authors (IFAs) are a unique set of guidelines for each publication.
This assists potential authors in correctly constructing their article and preparing it for submission.
Most "Instructions to Authors" pages are one or two links from the journal's homepage.
They are sometimes grouped under the following headings: Author Resources.
OA Publishing London is self-funded and receives no financing from any organization or government.
As a result, the Journals are funded entirely by processing fees collected from authors and academic/corporate sponsors.
The handling charge is necessary to cover its upkeep.
The Open Access Journal Group Journals do not collect subscription fees from readers who have free online access to the articles.
As a result, authors must pay a reasonable handling charge for processing their articles. There are, however, no submission fees.
Authors are obliged to pay only after their articles have been approved for publication.
- Select the information that will be given.
- When writing your novel, avoid typical traps.
- Determine who wrote what.
- Choose the journal to which the paper will be sent.
- Prepare and double-check your numbers, tables, and graphics.
- Examine all of your references.
The parties to an author agreement are often a writer or author and a publishing or production firm.
This kind of agreement is a legally binding contract.
The terms and conditions of a publishing contract between the two parties are spelled out in the reached agreement.